Why is 9G2.SI stock down in the pre-market session?

The pre-market fall to **S$0.048** likely reflects liquidity-driven selling and weak fundamentals, including low current ratio **0.31** and negative EPS. There is no major company news, so technical selling and sector pressure explain the top loser move.

What key metrics should investors watch for 9G2.SI stock?

Monitor working capital, operating cash flow per share, and receivables days. Watch levels **S$0.046** for downside risk and **S$0.062** (50-day average) for short-term recovery signals on the SES in SGD.

How reliable is the Meyka AI forecast for 9G2.SI stock?

Meyka AI's forecast model projects yearly **S$0.106**, implying **+121.05%** vs **S$0.048** today. Forecasts are model-based projections and not guarantees; they should be one input among fundamental and liquidity checks.

SG Stocks

Pre-market -7.69%: 9G2.SI Singapore Inst. of Advanced Med. (SES) Feb 2026: watch cash

ByDanny Kontos February 18, 2026February 18, 2026

Pre-market selling has knocked 9G2.SI stock down 7.69% to S$0.048 as of the pre-market session on 18 Feb 2026. Volume at 4,508,900 shares shows heavier trading than some recent sessions and points to urgent focus on liquidity. Singapore Institute of Advanced Medicine Holdings Ltd. (9G2.SI) trades on the SES in SGD and sits well below its 50-day average of S$0.062. For top losers in this pre-market window, we track cash ratios, debt metrics and the Meyka AI forecast to assess near-term downside risk and recovery triggers.